Patents Assigned to Merck Patent Gesellschaft mit beschrankter
  • METHOD FOR THE PREPARATION OF CIS-1,2-DIOLS IN THE KILOGRAM SCALE
    Publication number: 20130102640
    Abstract: The present invention relates to the scale up of the preparation of cis-1,2-diols of formula I from the gram to the kilogram scale.
    Type: Application
    Filed: June 3, 2011
    Publication date: April 25, 2013
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Werner Mederski, Georg Stoehr, Andreas Werner
  • 3 (3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives
    Patent number: 8426397
    Abstract: Compounds of the formula (I), in which R1, R2, R3, R3?, R4 have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumors.
    Type: Grant
    Filed: November 26, 2009
    Date of Patent: April 23, 2013
    Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
    Inventors: Dieter Dorsch, Oliver Schadt, Frank Stieber, Andree Blaukat
  • CROSS-LINKING AND MULTI-PHASE ETCH PASTES FOR HIGH RESOLUTION FEATURE PATTERNING
    Publication number: 20130092657
    Abstract: The present invention relates to a novel etching media in the form of printable, homogeneous etching pastes with non-Newtonian flow properties for the improved etching of inorganic oxides and silicon surfaces and which allow to prepare smaller features.
    Type: Application
    Filed: May 17, 2011
    Publication date: April 18, 2013
    Applicants: NANO TERRA, INC., MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Jennifer Gillies, Ralf Kuegler, Eric Stern, Brian Mayers, Patrick Reust, Lindsay Hunting
  • POLYMERIZABLE COMPOUNDS AND USE THEREOF IN LIQUID CRYSTAL DISPLAYS
    Publication number: 20130093975
    Abstract: The present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, and to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, especially in LC displays of the PS (“polymer sustained”) or PSA (“polymer sustained alignment”) type.
    Type: Application
    Filed: June 1, 2011
    Publication date: April 18, 2013
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Andreas Taugerbeck, Achim Goetz, Stephan Derow
  • Antibodies for the detection of integrin complexes in FFPE material
    Patent number: 8420348
    Abstract: The invention relates to antibodies that are capable to bind the extracellular domain of integrin. Another object of the invention concerns the use of said antibodies for detecting integrins in archival formalin fixed paraffin embedded (FFPE) tissue. The invention also relates to methods for preparing monoclonal rabbit antibodies, wherein the immunogen is an insect expression culture-derived recombinant extracellular integrin domain, and another method for screening anti-integrin antibodies that discriminate between closest integrin homologues and that are especially suited for immunohistochemistry in FFPE material.
    Type: Grant
    Filed: July 15, 2010
    Date of Patent: April 16, 2013
    Assignee: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Simon Goodman, Claudia Wilm, Francesc Mitjans
  • NOVEL SPECIFIC CASPASE-10 INHIBITORS
    Publication number: 20130090385
    Abstract: The invention relates to compounds of the general formula (I) wherein R1, R2, R3, R4, R5, R6, i and j have the meanings given in claim 1, and to the use thereof as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy.
    Type: Application
    Filed: November 28, 2012
    Publication date: April 11, 2013
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventor: Merck Patent Gesellschaft mit Beschrankter Haftu
  • OPTICAL SWITCH ELEMENT COMPRISING A LIQUID-CRYSTALLINE MEDIUM
    Publication number: 20130087738
    Abstract: The present invention relates to an optical switch element, comprising a liquid-crystalline medium for the temperature-dependent regulation of radiant energy flow. The invention furthermore relates to the use of the optical switch element for the regulation of radiant energy flow between interior spaces and the environment and for the regulation of the temperature of interior spaces. The invention furthermore relates to a liquid-crystalline medium, characterised in that it comprises 5-95% of a compound of the formula (I), in particular for use in the optical switch elements according to the invention.
    Type: Application
    Filed: May 4, 2011
    Publication date: April 11, 2013
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventor: Michael Junge
  • Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
    Patent number: 8415352
    Abstract: The present invention relates to quinoxalinone derivatives of formula (I): wherein R1, R2, R3, R4, R5 and R6 are as defined herein, as insulin secretion stimulators. Specific such quinoxaline compounds are also an aspect of the invention. The invention also relates to the preparation and use of these quinoxalinone derivatives for the prophylaxis and/or treatment of diabetes and pathologies associated.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: April 9, 2013
    Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
    Inventors: Gérard Botton, Eric Valeur, Micheline Kergoat, Christine Charon, Samer Elbawab
  • Particle beam process for the alignment of reactive mesogens
    Patent number: 8414983
    Abstract: The invention relates to a method of aligning reactive mesogens (RM) on a substrate subjected to particle beam treatment, to RM's oriented by said method, especially in form of thin layers, to oriented polymers and polymer films obtained from such oriented RM's and RM layers, and to the use of the RM's, layers, polymers and films in optical, electronic and electrooptical applications.
    Type: Grant
    Filed: August 10, 2007
    Date of Patent: April 9, 2013
    Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
    Inventors: Owain Llyr Parri, Alison Linda May, Julian Vaughan-Spickers, Karl Skjonnemand, Oleg Yaroshchuck
  • SWITCH ELEMENT COMPRISING A LIQUID-CRYSTALLINE MEDIUM
    Publication number: 20130083284
    Abstract: The present invention relates to a switch element, which is thermo-responsive and which switches between a less transmissive state for radiant energy and a more transmissive state for radiant energy, and which comprises a liquid-crystalline medium. The invention furthermore relates to the use of the switch element for the regulation of radiant energy flow between interior spaces and the environment and for the regulation of the temperature of interior spaces. The invention furthermore relates to a liquid-crystalline medium, characterised in that it comprises 5-60% of a compound of the formula (I), in particular for use in the switch elements according to the invention.
    Type: Application
    Filed: May 12, 2011
    Publication date: April 4, 2013
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventor: Michael Junge
  • Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
    Patent number: 8404685
    Abstract: Compounds of the formula I, in which R1, R2, R3, R3?, R4 and D have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumors.
    Type: Grant
    Filed: April 24, 2009
    Date of Patent: March 26, 2013
    Assignee: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Dieter Dorsch, Oliver Schadt, Frank Stieber, Andree Blaukat
  • FORMULATION AND METHOD FOR PREPARATION OF ORGANIC ELECTRONIC DEVICES
    Publication number: 20130069020
    Abstract: The present invention relates to novel formulations comprising an organic semiconductor (OSC) and one or more organic solvents. The formulation comprises a viscosity at 25° C. of less than 15 mPas and the boiling point of the solvent is at most 400° C. Furthermore, the present invention describes the use of these formulations as inks for the preparation of organic electronic (OE) devices, especially organic photovoltaic (OPV) cells and OLED devices, to methods for preparing OE devices using the novel formulations, and to OE devices, OLED devices and OPV cells prepared from such methods and formulations.
    Type: Application
    Filed: April 28, 2011
    Publication date: March 21, 2013
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Philip Edward May, Mark James, Piotr Wierzchowiec, Stephen Bain, Paul Craig Brookes, Edgar Kluge, Li Wei Tan, David Sparrowe, Magda Goncalves-Miskiewicz
  • Liquid-crystal medium
    Patent number: 8399073
    Abstract: The invention relates to a liquid-crystalline medium having negative dielectric anisotropy which comprises at least one compound of the formula I in which R1, R1* and a have the meanings indicated in Claim 1, and to the use thereof for an active-matrix display, in particular based on the VA, PS-VA, PALC, FFS or IPS effect.
    Type: Grant
    Filed: December 17, 2009
    Date of Patent: March 19, 2013
    Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
    Inventors: Melanie Klasen-Memmer, Matthias Bremer, Konstantin Schneider, Detlef Pauluth
  • Conjugated polymers and their use as organic semiconductors
    Patent number: 8398895
    Abstract: The invention relates to conjugated polymers that comprise phenanthrene and/or indenofluorene units and are free of amine-containing units, to methods of their preparation, to the use of the polymers in organic electronic (OE) devices, and to OE devices comprising the polymers.
    Type: Grant
    Filed: May 4, 2010
    Date of Patent: March 19, 2013
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: David Sparrowe, Niels Schulte, Frank Egon Meyer
  • Glucopyranoside derivatives
    Patent number: 8399509
    Abstract: Novel compounds of the formula (I), in which X has the meaning indicated in Patent Claim 1, are suitable as antidiabetics.
    Type: Grant
    Filed: March 17, 2009
    Date of Patent: March 19, 2013
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Christos Tsaklakidis, Norbert Beier
  • SELECTIVELY ETCHING OF A CARBON NANO TUBES (CNT) POLYMER MATRIX ON A PLASTIC SUBSTRUCTURE
    Publication number: 20130065359
    Abstract: The present invention refers to a method for selectively structuring of a polymer matrix comprising CNT (carbon nano tubes) on a flexible plastic substructure. The method also includes a suitable etching composition, which allows to proceed the method in a mass production.
    Type: Application
    Filed: April 26, 2011
    Publication date: March 14, 2013
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Werner Stockum, Arjan Meijer, Ingo Koehler
  • PHOSPHORS
    Publication number: 20130063926
    Abstract: The invention relates to mixtures comprising at least one phosphor of the formula I, AaLuc,CexAll,GamO12??(I) and at least one red-emitting phosphor, to a corresponding process for the preparation of these mixtures, and to the use thereof as conversion phosphors.
    Type: Application
    Filed: April 26, 2011
    Publication date: March 14, 2013
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Holger Winkler, Andreas Benker, Ralf Petry, Tim Vosgroene
  • Liquid crystalline medium and liquid crystal device
    Patent number: 8394467
    Abstract: The instant invention relates to dielectrically positive nematic media comprising one or more compounds of formula I and one or more compounds of formulae II and III and optionally one or more compounds of formulae IV and V and liquid crystal devices comprising these media and especially to fast switching electro-optical devices.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: March 12, 2013
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Yuko Arai, Takanori Takeda, Yasushi Sugiyama, Hideo Ichinose
  • Thiophene derivatives, and LC media containing same
    Patent number: 8394293
    Abstract: The present invention relates to thiophene derivatives, to processes and intermediates for the preparation thereof, to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, and to LC media and LC displays comprising same.
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: March 12, 2013
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Axel Jansen, Detlef Pauluth, Harald Hirschmann, Markus Czanta
  • Liquid-crystalline medium and liquid-crystal display
    Patent number: 8394292
    Abstract: The present invention relates to dielectrically positive liquid-crystalline media comprising a dielectrically neutral or slightly positive component, component A, comprising one or more dielectrically neutral or slightly positive compounds of the formula I in which the parameters have the meaning indicated in the specification, and a dielectrically positive component, component B, comprising one or more dielectrically positive compounds, and optionally a second dielectrically neutral component, component C, and to liquid-crystal displays containing these media, especially active-matrix displays and in particular TN, IPS and FFS displays.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: March 12, 2013
    Assignee: Merck Patent Gesellschaft mit beschränkter Haftung
    Inventors: Michael Wittek, Brigitte Schuler, Volker Reiffenrath